METiS Therapeutics
PrivateLast Round
IPO
May 13, 2026
Est. Valuation
$1.55B
Total Funding Raised
$305M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
METiS Therapeutics is a biotechnology company that leverages artificial intelligence, machine learning, and quantum simulation to drive drug discovery and optimize pharmaceutical formulation processes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
METiS Therapeutics Comparables
Compare METiS Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XtalPi | 85% | |
| Insilico Medicine | 80% | |
| Valo Health | 76% |
METiS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | May 13, 2026 | ||||
| Series D | Aug 4, 2025 | ||||
| Series C | Jun 24, 2024 | ||||
| Series B | Apr 6, 2022 | ||||
| Series A | Dec 7, 2021 | ||||
Angel | Dec 3, 2020 |
METiS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | IPO |
| IDG Capital | IPO |
| Lake Bleu Capital | IPO |
| CCIC Capital | Series D |
| Mirae Asset | IPO |
| Hillhouse Investment | IPO |
| 招银国际金融有限公司 | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 95% MoM.
- Dec 7, 2021
Raised $86M led by PICC Capital Insurance Asset Management.
METiS Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about METiS Therapeutics's valuation, stock price, and market status.
Is METiS Pharmaceuticals a public or private company?
METiS Pharmaceuticals is a private company.
What is the current stock price of METiS Pharmaceuticals?
METiS Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is METiS Pharmaceuticals worth (valuation)?
METiS Pharmaceuticals's valuation is estimated at $0 based on funding round data.
Can I buy METiS Pharmaceuticals stock?
METiS Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was METiS Pharmaceuticals's last funding round?
METiS Pharmaceuticals's most recent funding round was Series D on December 7, 2021.
Who are the main investors in METiS Pharmaceuticals?
Key investors in METiS Pharmaceuticals include China International Capital Corporation, PICC Capital Insurance Asset Management.
Will METiS Pharmaceuticals IPO soon?
No public IPO plans have been announced for METiS Pharmaceuticals.
How can I track METiS Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor METiS Pharmaceuticals's secondary market activity and sign up for updates.